InvestorsHub Logo
Followers 9
Posts 2581
Boards Moderated 0
Alias Born 04/15/2012

Re: None

Thursday, 04/24/2014 10:14:12 AM

Thursday, April 24, 2014 10:14:12 AM

Post# of 15274
Loprinzi reported RESULTS!!!

I was momentarily blinded when I read that the study results were actually available:

"clinicaltrials.gov/ct2/show/results/NCT01290224?term=loprinzi&rank=38§=X0125#all"

Okay, now let's see if I can interpret these.

Hmmmmm..."participant flow":

"STARTED 10 COMPLETED 5 NOT COMPLETED 5
Adverse Event 1
Refused Further Treatment 4"

Oooooooookay! So the study LOST HALF of its participants???? FORTY per cent REFUSED???? Another TEN per cent were lost due to an ADVERSE EFFECT????

Hoo-boy! Not exactly off to a blazing start, huh?

Then comes, "Percentage of Patients Who Have at Least a 50% Reduction":

"Sham Procedure 60
Scrambler Therapy 50"

In other words, the "sham" was MORE effective than the calmare!!!!
That's even WORSE than Dr. Campbell's results -- at least all he said was he couldn't tell any difference!

Loprinzi confirmed the results with a Mcnemar test that produced a "P Value" of "0.7630." That simply means that you cannot reject the "null hypothesis" of NO EFFECT due to the calmare treatment -- obvious enough since the sham and calmare produced nearly the same effects!

And what was the "adverse effect":

"Musculoskeletal/connective tissue disorder - achiness, fatigue and heaviness in bilateral lower legs"

Why, that sounds like it could be CRPS!! Calmare has the potential to induce CRPS???? Gasp! I wonder if that was reported to the FDA!

Gee, is Dr. Loprinzi presenting these "results" at ASCO?

If so, some people might want to rethink that "ASCO effect" business!


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.